ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ENTA on Nasdaq
Shares outstanding
29,149,043
Price per share
$15.77
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
18,990,940
Total reported value
$227,099,816
% of total 13F portfolios
0%
Share change
+569,289
Value change
+$8,890,506
Number of holders
119
Price from insider filings
$15.77
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% $41,823,994 3,494,068 JANUS HENDERSON GROUP PLC 31 Oct 2025
Farallon Capital Partners, L.P. 9.9% $11,953,846 2,108,262 Dapice Joshua J. 31 Dec 2024
Luly Jay R. 7.7% $9,659,503 1,703,616 Jay R. Luly, Ph.D. 12 Feb 2025
BlackRock, Inc. 7.8% $9,488,649 1,673,483 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 5.3% $17,769,621 1,484,513 Deep Track Capital, LP 02 Oct 2025
INTEGRATED CORE STRATEGIES (US) LLC 2.3% -45% $10,572,650 -$7,381,243 670,428 -41% Millennium Management LLC 31 Dec 2025

As of 30 Sep 2025, 119 institutional investors reported holding 18,990,940 shares of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA). This represents 65% of the company’s total 29,149,043 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FARALLON CAPITAL MANAGEMENT LLC 7.3% 2,122,262 0% 0.14% $25,403,476
Krensavage Asset Management, LLC 7.3% 2,114,444 0% 11% $25,310,000
JANUS HENDERSON GROUP PLC 6.7% 1,946,914 +272% 0.01% $23,285,091
VANGUARD GROUP INC 6.7% 1,938,829 -1.9% 0% $23,207,783
BlackRock, Inc. 6.3% 1,832,980 -0.75% 0% $21,940,770
MILLENNIUM MANAGEMENT LLC 3.3% 948,084 -35% 0.01% $11,348,565
ACADIAN ASSET MANAGEMENT LLC 3% 867,037 0% 0.02% $10,374,000
Commodore Capital LP 2.7% 800,000 0.47% $9,576,000
GEODE CAPITAL MANAGEMENT, LLC 1.7% 493,194 +1.5% 0% $5,904,427
RENAISSANCE TECHNOLOGIES LLC 1.6% 479,600 +2.2% 0.01% $5,740,812
STATE STREET CORP 1.6% 471,992 +0.37% 0% $5,649,744
Stonepine Capital Management, LLC 1% 305,000 -50% 3% $3,650,850
Point72 Asset Management, L.P. 1% 300,000 0.01% $3,590,999
MORGAN STANLEY 0.97% 282,631 -1.4% 0% $3,383,104
MARSHALL WACE, LLP 0.94% 275,389 -68% 0% $3,296,407
DIMENSIONAL FUND ADVISORS LP 0.93% 270,068 -2.7% 0% $3,235,361
AQR CAPITAL MANAGEMENT LLC 0.78% 226,845 -43% 0% $2,715,336
D. E. Shaw & Co., Inc. 0.77% 225,744 -20% 0% $2,702,156
NORTHERN TRUST CORP 0.67% 195,896 -22% 0% $2,344,875
JACOBS LEVY EQUITY MANAGEMENT, INC 0.58% 169,048 -12% 0.01% $2,023,505
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.57% 166,547 +1.2% 0% $1,993,568
GOLDMAN SACHS GROUP INC 0.57% 166,433 +43% 0% $1,992,203
Nuveen, LLC 0.57% 164,760 +267% 0% $1,972,177
Trexquant Investment LP 0.44% 127,363 -52% 0.02% $1,524,535
TANG CAPITAL MANAGEMENT LLC 0.43% 126,655 0% 0.06% $1,516,060

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 60,702 $933,791 -$139,191 $15.77 7
2025 Q3 18,990,940 $227,099,816 +$8,890,506 $11.97 119
2025 Q2 18,415,589 $139,218,163 -$1,130,233 $7.56 103
2025 Q1 18,625,766 $102,810,306 -$7,313,392 $5.52 108
2024 Q4 19,907,432 $114,464,576 -$17,702,481 $5.75 105
2024 Q3 21,229,862 $219,956,486 -$10,189,778 $10.36 110
2024 Q2 22,131,926 $287,039,395 -$4,639,003 $12.97 99
2024 Q1 22,403,789 $391,166,955 +$45,279,493 $17.46 105
2023 Q4 20,026,111 $188,441,196 -$5,171,233 $9.41 103
2023 Q3 20,144,110 $225,005,701 -$8,699,698 $11.17 129
2023 Q2 19,936,779 $426,629,256 -$15,765,200 $21.40 129
2023 Q1 19,836,693 $802,018,224 +$23,678,858 $40.44 142
2022 Q4 19,243,859 $895,247,833 -$44,744,222 $46.52 145
2022 Q3 19,726,320 $1,023,129,229 -$26,641,297 $51.87 155
2022 Q2 20,231,748 $956,338,910 +$17,270,558 $47.27 149
2022 Q1 19,671,490 $1,399,487,075 +$60,693,984 $71.18 163
2021 Q4 18,780,733 $1,403,536,269 -$51,376,670 $74.78 172
2021 Q3 19,379,501 $1,101,045,074 +$34,578,566 $56.81 140
2021 Q2 18,825,846 $828,634,567 -$26,899,911 $44.01 147
2021 Q1 19,430,818 $956,710,887 +$7,403,943 $49.32 146
2020 Q4 19,261,435 $811,015,243 +$16,262,569 $42.10 148
2020 Q3 18,857,563 $863,147,048 +$27,242,369 $45.78 170
2020 Q2 18,268,221 $917,098,781 +$10,521,228 $50.21 173
2020 Q1 18,020,619 $927,779,000 -$32,712,586 $51.43 154
2019 Q4 18,412,053 $1,137,352,094 +$22,036,868 $61.78 166
2019 Q3 17,893,697 $1,075,047,568 +$8,725,519 $60.08 172
2019 Q2 17,650,303 $1,489,161,032 -$2,593,033 $84.38 192
2019 Q1 17,808,189 $1,700,970,450 +$95,436,368 $95.52 195
2018 Q4 16,787,790 $1,189,003,666 +$7,018,079 $70.83 179
2018 Q3 16,614,214 $1,420,009,073 +$117,858,050 $85.46 193
2018 Q2 15,086,991 $1,748,431,673 +$46,828,949 $115.90 188
2018 Q1 14,743,245 $1,192,925,026 +$63,018,725 $80.91 177
2017 Q4 14,015,489 $822,445,465 +$75,200,938 $58.68 139
2017 Q3 12,779,810 $597,980,830 +$18,398,348 $46.80 122
2017 Q2 12,614,190 $453,888,968 -$5,704,439 $35.98 118
2017 Q1 12,846,377 $395,666,818 +$44,283,496 $30.80 123
2016 Q4 13,334,548 $446,581,457 +$14,267,822 $33.50 146
2016 Q3 13,117,480 $348,994,653 +$837,826 $26.61 133
2016 Q2 13,419,466 $295,897,870 -$1,389,083 $22.05 126
2016 Q1 14,240,811 $418,192,732 -$10,122,533 $29.37 150
2015 Q4 14,626,888 $483,060,372 -$20,743,890 $33.02 132
2015 Q3 14,924,031 $539,846,889 +$48,649,314 $36.14 141
2015 Q2 13,813,121 $620,989,034 +$81,244,568 $44.99 129
2015 Q1 12,341,155 $378,314,987 +$43,094,457 $30.62 115
2014 Q4 10,443,495 $530,912,559 +$20,770,064 $50.85 122
2014 Q3 10,012,073 $396,154,426 +$13,350,733 $39.57 109
2014 Q2 9,666,018 $416,088,660 +$53,128,968 $43.07 97
2014 Q1 8,437,120 $337,235,708 +$157,537,636 $39.99 79